Criminal Accusation against Nobaruteisu Huama K.K.
Action summary
- Company
- Nobaruteisu Huama K.K.RomanizedOriginal: ノバルティス ファーマ株式会社Corporate Number: 4010401011491
- Governing law
- 薬事法薬事法
- Action type
- Criminal Accusation告発
- Action date
- January 9, 2014
- Issuing authority
- Ministry of Health, Labour and Welfare厚生労働省
Violation
Novartis Pharma K.K. used materials that described the results of clinical studies, the 'JIKEI HEART Study' conducted at Tokyo Jikei Medical University and the 'KYOTO HEART Study' conducted at Kyoto Prefectural University of Medicine, to advertise the efficacy or effects of the drug Diovan tablets. These advertisements were made using the results of these clinical studies.
Show original Japanese text
ノバルティス ファーマ株式会社は、平成23年から平成24年にかけて、ディオバン錠に係る東京慈恵会医科大学において実施された臨床研究である「JIKEI HEART Study」及び京都府立医科大学において実施された臨床研究である「KYOTO HEART Study」の結果を記載した資材を用いて、同医薬品の効能又は効果に関して広告を行った。
Source
Original Ministry of Health, Labour and Welfare announcement (in Japanese)The original Japanese disclosure is the authoritative record.
Watch this company
Get an email when Nobaruteisu Huama K.K. has new enforcement actions or registry changes (representative, address, business status). Sign-in is via a one-time email link — no password.
Language
日本語版を見る (Japanese)Company info
- English name
- Nobaruteisu Huama K.K. Romanized
- Japanese name
- ノバルティス ファーマ株式会社
- Corporate Number
- 4010401011491
- Registered address
- 東京都港区虎ノ門１丁目２３番１号
About this recordAggregated and translated from public Japanese government disclosures. The English text is for reference only — authoritative content is the linked Japanese source.